Answers are grounded in this paper and cite their sources.
Reveals palmitic acid's role in driving MASLD in offspring, suggesting new treatment targets.
Introduction and Objective: Early-life environmental exposures program long-term physiology and disease susceptibility in adulthood. Specifically, the intrauterine environments shaped by maternal overnutrition are implicated to drive the metabolic dysregulated in offspring. However, the precise mechanisms by which maternal overnutrition exacerbates hepatic steatosis and metabolic dysfunction-associated steatotic liver disease (MASLD) in offspring remain largely unknown. Methods: 8-week-old wild-type C57BL/6J female mice either a standard chow diet or a high-fat high-sucrose (HFHS) diet throughout gestation and lactation period. Following weaning, offspring were maintained on standard chow diet for 5 weeks, then switched to an HFHS diet for 16 weeks. RNA-seq was performed to identify FABP1 as a critical mediator of offspring hepatic lipogenesis. ChIP-seq was employed to assess the role of histone H3K4me3 modification in regulating FABP1 expression. Results: We identified fatty acid binding protein 1 (FABP1) as an essential mediator linking maternal overnutrition to offspring MASLD pathogenesis. Hepatic FABP1 is significantly upregulated in offspring exposed to maternal HFHS diet. FABP1 deficiency protects offspring from maternal overnutrition-induced hepatic steatosis and MASLD. Interestingly, palmitic acid specifically increases the production of FABP1 and enhances hepatic lipogenesis by inducing histone H3K4me3 modification. Mechanistically, FABP1 signals palmitic acid sufficiency to activate mTORC1 and lipogenesis by potentiating GATOR2 stabilization. In humans, neonatal serum levels of FABP1 are upregulated and positively correlated with maternal overnutrition and obesity. Conclusion: Collectively, our findings uncover the underlying mechanism by which maternal overnutrition exacerbates offspring MASLD progression, and highlighting the potential of targeting the palmitic acid-FABP1-H3K4me3 signaling to treat maternal overnutrition-induced MASLD and systemic metabolic disorders. Disclosure Z. Zheng: None. D. Ding: None. G. Cai: None. Y. Liu: None. M. Huang: None. J. Wen: None. J. Lin: None. J. Shen: None. W. Li: None. S. Wei: None. B. Xing: None. P. Hu: None. L. Xu: None. H. Yu: None. Y. Ni: None. Y. He: None. Y. Jiang: None. Z. Hu: None. W. Su: None. Y. Li: None. Funding Noncommunicable Chronic Diseases-National Science and Technology Major Project (2024ZD0531300), Strategic Priority Research Program of the Chinese Academy of Science (XDB1150000), National Key R&D Program of China (2023YFA1801100, 2019YFA0802502), National Natural Science Foundation of China (32130047), Shanghai Municipal Science and Technology Major Project, Postdoctoral Fellowship Program of CPSF (GZC20251002) and Natural Science Foundation of Shanghai (24ZR1478200)
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: